Zhejiang Jolly Pharmaceutical Co Ltd (300181) — Free Cash Flow Generation Index
Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a Free Cash Flow Generation Index of 0.95x as of June 2025. Free cash flow of CN¥347.08 Million represents 1% of operating cash flow (CN¥367.02 Million). Explore Zhejiang Jolly Pharmaceutical Co Ltd (300181) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang Jolly Pharmaceutical Co Ltd Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for Zhejiang Jolly Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see Zhejiang Jolly Pharmaceutical Co Ltd (300181) cash flow conversion.
Annual Free Cash Flow Generation for Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
Year-by-year Free Cash Flow Generation Index for Zhejiang Jolly Pharmaceutical Co Ltd. Check Zhejiang Jolly Pharmaceutical Co Ltd (300181) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.30x | CN¥124.66 Million | CN¥411.80 Million | CN¥287.14 Million | ▲ +163.2% |
| 2024 | 0.11x | CN¥34.16 Million | CN¥297.05 Million | CN¥262.89 Million | ▼ -78.8% |
| 2023 | 0.54x | CN¥156.75 Million | CN¥288.46 Million | CN¥131.71 Million | ▲ +23.2% |
| 2022 | 0.44x | CN¥140.56 Million | CN¥318.59 Million | CN¥178.03 Million | ▲ +7.0% |
| 2021 | 0.41x | CN¥103.84 Million | CN¥251.80 Million | CN¥147.95 Million | ▼ -47.9% |
| 2020 | 0.79x | CN¥221.34 Million | CN¥279.69 Million | CN¥58.35 Million | ▲ +15.3% |
| 2019 | 0.69x | CN¥88.48 Million | CN¥128.94 Million | CN¥40.46 Million | ▲ +171.0% |
| 2018 | -0.97x | CN¥-75.64 Million | CN¥78.28 Million | CN¥153.92 Million | ▲ +94.7% |
| 2017 | -18.12x | CN¥-117.89 Million | CN¥6.51 Million | CN¥124.40 Million | ▼ -1143.8% |
| 2016 | -1.46x | CN¥-84.94 Million | CN¥58.30 Million | CN¥143.24 Million | ▼ -299.2% |
| 2015 | 0.73x | CN¥71.04 Million | CN¥97.13 Million | CN¥26.08 Million | ▲ +139.1% |
| 2014 | -1.87x | CN¥-25.60 Million | CN¥13.70 Million | CN¥39.30 Million | ▼ -1055.4% |
| 2013 | 0.20x | CN¥5.77 Million | CN¥29.50 Million | CN¥23.73 Million | ▲ +191.3% |
| 2012 | -0.21x | CN¥-6.54 Million | CN¥30.51 Million | CN¥37.05 Million | ▲ +93.9% |
| 2011 | -3.49x | CN¥-47.67 Million | CN¥13.65 Million | CN¥61.32 Million | ▼ -966.6% |
| 2010 | 0.40x | CN¥26.10 Million | CN¥64.78 Million | CN¥38.68 Million | ▼ -27.2% |
| 2009 | 0.55x | CN¥24.30 Million | CN¥43.89 Million | CN¥19.60 Million | ▼ -7.6% |
| 2008 | 0.60x | CN¥18.66 Million | CN¥31.16 Million | CN¥12.50 Million | ▲ +38.7% |
| 2007 | 0.43x | CN¥6.93 Million | CN¥16.05 Million | CN¥9.12 Million | — |